Related Experiment Video
Updated: Jan 30, 2026
05:07
Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network
Published on: February 16, 2016
11.4K
Inflammation and immunity in IPF pathogenesis and treatment
P Heukels1, C C Moor2, J H von der Thüsen3
1Department of Pulmonary Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands; Department of Pulmonary Medicine, Amphia Hospital Breda, Breda, the Netherlands.
Respiratory Medicine
|February 2, 2019
Summary
Idiopathic pulmonary fibrosis (IPF) involves immune responses in its progression. Understanding these immune mechanisms is key to developing new therapies for this fatal lung disease.
Area of Science:
- Pulmonary Medicine
- Immunology
- Fibrosis Research
Background:
- Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease marked by excessive extracellular matrix deposition.
- Repetitive lung injury and impaired repair lead to progressive fibrosis in IPF.
- Immune responses are present in all stages of IPF, though their role is debated.
Purpose of the Study:
- To review the role of innate and adaptive immune systems in IPF pathobiology.
- To discuss how current anti-fibrotic drugs affect immune responses in IPF.
- To provide an overview of emerging immunomodulatory therapies for IPF.
Main Methods:
- Literature review focusing on immune system involvement in IPF.
- Analysis of current understanding of immune cell interactions in fibrosis.
- Summary of clinical trials targeting immune pathways in IPF.
Main Results:
- New insights highlight the roles of macrophages, T-cells, and B-cells in IPF.
- Immune cells interact with (myo)fibroblasts, contributing to tissue remodeling.
- Existing treatments like pirfenidone and nintedanib influence immune responses.
Conclusions:
- The immune system plays a critical role in IPF initiation and progression.
- Further research integrating immune mechanisms is needed for novel IPF therapies.
- Targeting immune modulation presents a promising therapeutic strategy for IPF patients.
Related Concept Videos
01:38Inflammation
62.0K
Overview
62.0K
01:38What is the Immune System?
127.7K
Overview
127.7K
01:30Pulmonary Hypertension: Classification and Pathogenesis
636
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
636
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
01:23Cystic Fibrosis: Pathogenesis
871
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
871
01:20COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K